Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention

被引:67
作者
Chu, WW [1 ]
Rha, SW [1 ]
Kuchulakanti, PK [1 ]
Cheneau, E [1 ]
Torguson, R [1 ]
Pinnow, E [1 ]
Alexieva-Fournadjiev, J [1 ]
Pichard, AD [1 ]
Satler, LF [1 ]
Kent, KM [1 ]
Lindsay, J [1 ]
Waksman, R [1 ]
机构
[1] Washington Hosp Ctr, Washington, DC 20010 USA
关键词
D O I
10.1016/j.amjcard.2005.08.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Saphenous vein graft (SVG) intervention is associated with a significantly increased rate of periprocedural complications and late clinical and angiographic restenosis. We examined the efficacy and safety of sirolimus-eluting stents (SESs; Cypher) compared with bare metal stents (BMSs) in SVG intervention. Forty-eight patients who had 50 SVG lesions and underwent standard percutaneous coronary intervention with SESs (SES group) were compared with 57 patients who had 64 SVG lesions and underwent intervention with BMSs (BMS group). All patients received distal protection devices during SVG intervention. In-hospital, 30-day, 6-month, and 1-year clinical outcomes in the 2 groups were compared. Baseline clinical and procedural characteristics were balanced between groups. There were no deaths or Q-wave myocardial infarctions during the index hospitalization, but compared with the BMS group, patients in the SES group had significantly fewer non-Q-wave myocardial infarctions (4% vs 21%, p = 0.01), which was mainly attributed to increased periprocedural creatine kinase-MB levels. At 30-day, 6-month, and 1-year follow-ups, all clinical outcomes were similar between groups. Event-free survival at 1 year was also similar between groups (p = 0.84). In conclusion, the use of SESs in patients who undergo SVG intervention with a distal protection device is clinically safe and feasible but is not associated with decreased clinical events up to 1 year compared with BMSs. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:34 / 37
页数:4
相关论文
共 17 条
[1]   Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts [J].
Baim, DS ;
Wahr, D ;
George, B ;
Leon, MB ;
Greenberg, J ;
Cutlip, DE ;
Kaya, U ;
Popma, JJ ;
Ho, KKL ;
Kuntz, RE .
CIRCULATION, 2002, 105 (11) :1285-1290
[2]   Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting [J].
Bhargava, B ;
Kornowski, R ;
Mehran, R ;
Kent, KM ;
Hong, MK ;
Lansky, AJ ;
Waksman, R ;
Pichard, AD ;
Satler, LF ;
Leon, MB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :389-397
[3]   LOSS OF THE IMPROVEMENT OF ANGINA BETWEEN 1 AND 7 YEARS AFTER AORTOCORONARY BYPASS SURGERY - CORRELATIONS WITH CHANGES IN VEIN GRAFTS AND IN CORONARY-ARTERIES [J].
CAMPEAU, L ;
LESPERANCE, J ;
HERMANN, J ;
CORBARA, F ;
GRONDIN, CM ;
BOURASSA, MG .
CIRCULATION, 1979, 60 (02) :I1-I5
[4]   Long-term clinical outcome after stent implantation in saphenous vein grafts [J].
deJaegere, PP ;
vanDomburg, RT ;
deFeyter, PJ ;
Ruygrok, PN ;
vanderGiessen, WJ ;
vandenBrand, MJ ;
Serruys, PW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (01) :89-96
[5]   CORONARY-BYPASS GRAFT FATE - LONG-TERM ANGIOGRAPHIC STUDY [J].
FITZGIBBON, GM ;
LEACH, AJ ;
KAFKA, HP ;
KEON, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (05) :1075-1080
[6]   Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years [J].
FitzGibbon, GM ;
Kafka, HP ;
Leach, AJ ;
Keon, WJ ;
Hooper, GD ;
Burton, JR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (03) :616-626
[7]   Treatment of saphenous vein graft lesions with drug-eluting stents - Immediate and midterm outcome [J].
Ge, L ;
Iakovou, I ;
Sangiorgi, GM ;
Chieffo, A ;
Melzi, G ;
Cosgrave, J ;
Montorfano, M ;
Michev, I ;
Airoldi, F ;
Carlino, M ;
Corvaja, N ;
Colombo, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) :989-994
[8]   Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality [J].
Hong, MK ;
Mehran, R ;
Dangas, G ;
Mintz, GS ;
Lansky, AJ ;
Pichard, AD ;
Kent, KM ;
Satler, LF ;
Stone, GW ;
Leon, MB .
CIRCULATION, 1999, 100 (24) :2400-2405
[9]   Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome [J].
Iakovou, I ;
Dangas, G ;
Mintz, GS ;
Mehran, R ;
Kobayashi, Y ;
Aymong, ED ;
Hirose, M ;
Ashby, DT ;
Lansky, AJ ;
Stone, GW ;
Leon, MB ;
Moses, JW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08) :963-968
[10]   Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts [J].
Keeley, EC ;
Velez, CA ;
O'Neill, WW ;
Safian, RD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :659-665